tiprankstipranks
Trending News
More News >
Guangzhou Baiyunshan Pharmaceutical Holdings Company Class H (GZPHF)
:GZPHF
US Market
Advertisement

Guangzhou Baiyunshan Pharmaceutical Holdings Company (GZPHF) Stock Forecast & Price Target

Compare
4 Followers
See the Price Targets and Ratings of:

GZPHF Analyst Ratings

Currently, no data available
Based on NaN analysts giving stock ratings to
Guangzhou
Baiyunshan Pharmaceutical Holdings Company
in the past 3 months
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers​ in the past 3 months

GZPHF Stock 12 Month Forecast

There Are No Analyst Ratings for GZPHF In The Last 3 Months.
Highest Price TargetAverage Price TargetLowest Price Target
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

GZPHF Financial Forecast

GZPHF Earnings Forecast

The previous quarter’s earnings for GZPHF were $0.07.
The previous quarter’s earnings for GZPHF were $0.07.

GZPHF Sales Forecast

The previous quarter’s earnings for GZPHF were $2.78B.
The previous quarter’s earnings for GZPHF were $2.78B.

Detailed List of Analyst Forecasts​

Detailed List of Analyst Forecasts​
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
TR | OpenAI - 4o Analyst forecast on GZPHF
TR | OpenAI - 4o
TR | OpenAI - 4o
$2.57$2.7
Buy
15.43%
Upside
Reiterated
10/31/25
AI Generated ArticleAI Generated Article
Citi Analyst forecast on GZPHF
Unknown Analyst
Citi
Not Ranked
Citi
$1.86
Sell
-20.30%
Downside
Reiterated
08/27/25
Bank of America Securities Analyst forecast on GZPHF
Unknown Analyst
Bank of America Securities
Not Ranked
Bank of America Securities
$2.83
Buy
20.92%
Upside
Reiterated
08/18/25
Morgan Stanley Analyst forecast on GZPHF
Morgan Stanley
Morgan Stanley
$2.79$2.75
Hold
17.63%
Upside
Reiterated
12/23/24
Guangzhou Baiyunshan Pharma (874:HK) PT Lowered to HK$21.40 at Morgan StanleyMorgan Stanley analyst Laurence Tam lowered the price target on Guangzhou Baiyunshan Pharma (874:HK) to HK$21.40 (from HK$21.70) while maintaining a Equalweight rating.
Ranks
Any
Any
Analyst Rating
Any
Any
Upside/ Downside
Any
Any
Action
Any
Any
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
TR | OpenAI - 4o Analyst forecast on GZPHF
TR | OpenAI - 4o
TR | OpenAI - 4o
$2.57$2.7
Buy
15.43%
Upside
Reiterated
10/31/25
AI Generated ArticleAI Generated Article
Citi Analyst forecast on GZPHF
Unknown Analyst
Citi
Not Ranked
Citi
$1.86
Sell
-20.30%
Downside
Reiterated
08/27/25
Bank of America Securities Analyst forecast on GZPHF
Unknown Analyst
Bank of America Securities
Not Ranked
Bank of America Securities
$2.83
Buy
20.92%
Upside
Reiterated
08/18/25
Morgan Stanley Analyst forecast on GZPHF
Morgan Stanley
Morgan Stanley
$2.79$2.75
Hold
17.63%
Upside
Reiterated
12/23/24
Guangzhou Baiyunshan Pharma (874:HK) PT Lowered to HK$21.40 at Morgan StanleyMorgan Stanley analyst Laurence Tam lowered the price target on Guangzhou Baiyunshan Pharma (874:HK) to HK$21.40 (from HK$21.70) while maintaining a Equalweight rating.
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Guangzhou Baiyunshan Pharmaceutical Holdings Company

1 Month
xxx
Success Rate
1/3 ratings generated profit
33%
Average Return
+0.73%
reiterated a xxx
rating 8 days ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 1 Month would result in 33.33% of your transactions generating a profit, with an average return of +0.73% per trade.
3 Months
xxx
Success Rate
1/3 ratings generated profit
33%
Average Return
+0.73%
reiterated a xxx
rating 8 days ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 3 Months would result in 33.33% of your transactions generating a profit, with an average return of +0.73% per trade.
1 Year
Bryce GeneronTR | OpenAI - 4o
Success Rate
1/3 ratings generated profit
33%
Average Return
+0.73%
reiterated a buy rating 8 days ago
Copying Bryce Generon's trades and holding each position for 1 Year would result in 33.33% of your transactions generating a profit, with an average return of +0.73% per trade.
2 Years
xxx
Success Rate
1/3 ratings generated profit
33%
Average Return
+0.73%
reiterated a xxx
rating 8 days ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 2 Years would result in 33.33% of your transactions generating a profit, with an average return of +0.73% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

GZPHF Analyst Recommendation Trends

Rating
Dec 24
Feb 25
Apr 25
Aug 25
Oct 25
Strong Buy
0
0
0
2
6
Buy
0
0
1
1
1
Hold
3
2
2
1
1
Sell
0
1
1
2
1
Strong Sell
0
0
0
0
0
total
3
3
4
6
9
In the current month, GZPHF has received 7 Buy Ratings, 1 Hold Ratings, and 1 Sell Ratings. GZPHF average Analyst price target in the past 3 months is .
Each month's total comprises the sum of three months' worth of ratings.

GZPHF Stock Forecast FAQ

What is GZPHF’s average 12-month price target, according to analysts?
Currently, no data Available
What is GZPHF’s upside potential, based on the analysts’ average price target?
Currently there's no upside potential for GZPHF, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
    How can I follow the stock ratings of top Wall Street analysts?
    Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
      Is GZPHF a Buy, Sell or Hold?
      Currently, no data Available
      What is Guangzhou Baiyunshan Pharmaceutical Holdings Company Class H’s price target?
      Currently, no data Available
      What do analysts say about Guangzhou Baiyunshan Pharmaceutical Holdings Company Class H?
      Not enough analysts have published a price target to provide an average price target.
      How can I buy shares of GZPHF?
      Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.
        What am I Missing?
        Make informed decisions based on Top Analysts' activity
        Know what industry insiders are buying
        Get actionable alerts from top Wall Street Analysts
        Find out before anyone else which stock is going to shoot up
        Get powerful stock screeners & detailed portfolio analysis